Nanotherapeutics, Inc.

Click Here To EMAIL INQUIRY
Contact: James D. Talton, Ph.D. - President & CEO
Web: http://www.nanotherapeutics.com
E-Mail:
Address: 13859 Progress Blvd, Suite 300, Alachua, Florida 32615, USA
Phone: +1-(386)-462-9663 | Fax: +1-(386)-462-2087 | Map/Directions >>

Profile: Nanotherapeutics, Inc. specializes in product formulation, development, scale-up and manufacture, utilizing existing as well as proprietary techniques that can improve the release rate & enhance both the rate & extent of drug uptake, thus increasing bioavailability. Our proprietary techniques include NanoQUAD™, NanoDRY™, and NanoCOAT™. Our Origen™ DBM with bioactive glass is a bone void filler comprised of a gelatin carrier, bioactive glass (45s5) and human demineralized bone matrix (DBM) intended for transplantation. It has been formulated to reconstitute into a paste upon addition of a sterile fluid such as sterile saline, and water for injection. It is provided in a sterile, single-use syringe.

FDA Registration Number: 3005565760

3 Products/Services (Click for related suppliers)

• Calcium Compound Bone Void Filler (FDA Code: MQV / 888.3045)

A resorbable calcium salt bone void filler device is a resorbable implant intended to fill bony voids or gaps of the extremities, spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure.

• Nasal Influenza Vaccines

• Osteoinduction Bone Void Filler (FDA Code: MBP / 888.3045)